Oliver Politz
- Immunology top 5%
- Biotechnology top 2%
- Enzyme Production and Characterization 7
- Immunology and Allergy top 5%
- Oncology top 5%
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 9
- Fibroblast Growth Factor Research 4
-
- Biofuel production and bioconversion 7
-
- Lymphoma Diagnosis and Treatment 6
-
- Chronic Lymphocytic Leukemia Research 5
-
- Advanced Breast Cancer Therapies 5
- Prostate Cancer Treatment and Research 5
Oliver Politz
52 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 107
- Immunology 801
- Biotechnology 256
- Immunology and Allergy 129
- Oncology 456
- Molecular Biology 1.0k
Countries citing papers authored by Oliver Politz
This map shows the geographic impact of Oliver Politz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Politz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Politz more than expected).
Fields of papers citing papers by Oliver Politz
This network shows the impact of papers produced by Oliver Politz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Politz. The network helps show where Oliver Politz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oliver Politz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 32 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 3 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 20 | |
| 9 | 2017 | 3 | |
| 10 | 2016 | 66 | |
| 11 | 2004 | 56 | |
| 12 | 2004 | 90 | |
| 13 | 2002 | 247 | |
| 14 | 2001 | 231 | |
| 15 | 2000 | 59 | |
| 16 | 1998 | 8 | |
| 17 | 1996 | 10 | |
| 18 | 1995 | 98 | |
| 19 | 1995 | 15 | |
| 20 | 1993 | 32 |
About Oliver Politz
Oliver Politz is a scholar working on Biotechnology, Cancer Research, Immunology, Immunology and Allergy and Genetics, having authored 53 papers that have together received 2.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Biofuel production and bioconversion (7 papers), Enzyme Production and Characterization (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Advanced Breast Cancer Therapies (5 papers), Prostate Cancer Treatment and Research (5 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Immunology (801 citations), Biotechnology (256 citations), Immunology and Allergy (129 citations), Oncology (456 citations) and Molecular Biology (1.0k citations). Oliver Politz has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Sergij Goerdt, Vitam Kodelja, Kai Schledzewski, Pierre Guillot, Alexei Gratchev, C. Müller, Rainer Borriss, Nahid Hakiy, Bernard Haendler and C.E. Orfanos. Their work appears in journals such as Cancer Research, European Journal of Biochemistry, Molecular Cancer Therapeutics, British Journal of Haematology and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.